BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37055858)

  • 21. Identifying novel chemical-related susceptibility genes for five psychiatric disorders through integrating genome-wide association study and tissue-specific 3'aQTL annotation datasets.
    Shi S; Zhang H; Chu X; Cai Q; He D; Qin X; Wei W; Zhang N; Zhao Y; Jia Y; Zhang F; Wen Y
    Eur Arch Psychiatry Clin Neurosci; 2024 Feb; ():. PubMed ID: 38305800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sex differences in the association of treatment-resistant schizophrenia and serum interleukin-6 levels.
    He J; Wei Y; Li J; Tang Y; Liu J; He Z; Zhou R; He X; Ren H; Liao Y; Gu L; Yuan N; Chen X; Tang J
    BMC Psychiatry; 2023 Jun; 23(1):470. PubMed ID: 37370004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identifying novel proteins underlying loneliness by integrating GWAS summary data with human brain proteomes.
    Gu X; Dou M; Yuan M; Zhang W
    Neuropsychopharmacology; 2023 Jun; 48(7):1087-1097. PubMed ID: 36755143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genome-wide genetic analyses highlight mitogen-activated protein kinase (MAPK) signaling in the pathogenesis of endometriosis.
    Uimari O; Rahmioglu N; Nyholt DR; Vincent K; Missmer SA; Becker C; Morris AP; Montgomery GW; Zondervan KT
    Hum Reprod; 2017 Apr; 32(4):780-793. PubMed ID: 28333195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterizing the Causal Pathway for Genetic Variants Associated with Neurological Phenotypes Using Human Brain-Derived Proteome Data.
    Kibinge NK; Relton CL; Gaunt TR; Richardson TG
    Am J Hum Genet; 2020 Jun; 106(6):885-892. PubMed ID: 32413284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identifying causal genes for stroke via integrating the proteome and transcriptome from brain and blood.
    Wu BS; Chen SF; Huang SY; Ou YN; Deng YT; Chen SD; Dong Q; Yu JT
    J Transl Med; 2022 Apr; 20(1):181. PubMed ID: 35449099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased schizophrenia family history burden and reduced premorbid IQ in treatment-resistant schizophrenia: a Swedish National Register and Genomic Study.
    Kowalec K; Lu Y; Sariaslan A; Song J; Ploner A; Dalman C; Hultman CM; Larsson H; Lichtenstein P; Sullivan PF
    Mol Psychiatry; 2021 Aug; 26(8):4487-4495. PubMed ID: 31712719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA methylation signature aberration as potential biomarkers in treatment-resistant schizophrenia: Constructing a methylation risk score using a machine learning method.
    Lu AK; Lin JJ; Tseng HH; Wang XY; Jang FL; Chen PS; Huang CC; Hsieh S; Lin SH
    J Psychiatr Res; 2023 Jan; 157():57-65. PubMed ID: 36442407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polygenic Risk Score for Schizophrenia and Treatment-Resistant Schizophrenia.
    Wimberley T; Gasse C; Meier SM; Agerbo E; MacCabe JH; Horsdal HT
    Schizophr Bull; 2017 Sep; 43(5):1064-1069. PubMed ID: 28184875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of novel proteins for sleep apnea by integrating genome-wide association data and human brain proteomes.
    Gui J; Meng L; Huang D; Wang L; Yang X; Ding R; Han Z; Cheng L; Jiang L
    Sleep Med; 2024 Feb; 114():92-99. PubMed ID: 38160582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GSTM1/GSTT1 double-null genotype increases risk of treatment-resistant schizophrenia: A genetic association study in Brazilian patients.
    Pinheiro DS; Santos RDS; de Brito RB; Cruz AHDS; Ghedini PC; Reis AAS
    PLoS One; 2017; 12(8):e0183812. PubMed ID: 28837637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma proteome analysis implicates novel proteins as potential therapeutic targets for chronic kidney disease: A proteome-wide association study.
    Xiong Y; Wang T; Wang W; Zhang Y; Zhang F; Yuan J; Qin F; Wang X
    Heliyon; 2024 Jun; 10(11):e31704. PubMed ID: 38828357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrating human brain proteomes with genome-wide association data implicates new proteins in Alzheimer's disease pathogenesis.
    Wingo AP; Liu Y; Gerasimov ES; Gockley J; Logsdon BA; Duong DM; Dammer EB; Robins C; Beach TG; Reiman EM; Epstein MP; De Jager PL; Lah JJ; Bennett DA; Seyfried NT; Levey AI; Wingo TS
    Nat Genet; 2021 Feb; 53(2):143-146. PubMed ID: 33510477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain proteome-wide association study linking-genes in multiple sclerosis pathogenesis.
    Jia T; Ma Y; Qin F; Han F; Zhang C
    Ann Clin Transl Neurol; 2023 Jan; 10(1):58-69. PubMed ID: 36475386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A preliminary genetic association study of GAD1 and GABAB receptor genes in patients with treatment-resistant schizophrenia.
    Miyazawa A; Kanahara N; Kogure M; Otsuka I; Okazaki S; Watanabe Y; Yamasaki F; Nakata Y; Oda Y; Hishimoto A; Iyo M
    Mol Biol Rep; 2022 Mar; 49(3):2015-2024. PubMed ID: 34845648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association study between Disrupted-in-Schizophrenia-1 (DISC1) and Japanese patients with treatment-resistant schizophrenia (TRS).
    Hotta Y; Ohnuma T; Hanzawa R; Shibata N; Maeshima H; Baba H; Hatano T; Takebayashi Y; Kitazawa M; Higa M; Suzuki T; Arai H
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):636-9. PubMed ID: 21256178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genome-Wide Variants Shared Between Smoking Quantity and Schizophrenia on 15q25 Are Associated With CHRNA5 Expression in the Brain.
    Ohi K; Kuwata A; Shimada T; Kataoka Y; Yasuyama T; Uehara T; Kawasaki Y
    Schizophr Bull; 2019 Jun; 45(4):813-823. PubMed ID: 30202994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrating genome-wide association study with regulatory SNP annotation information identified candidate genes and pathways for schizophrenia.
    Liang X; Wang S; Liu L; Du Y; Cheng B; Wen Y; Zhao Y; Ding M; Cheng S; Ma M; Zhang L; Qi X; Li P; Guo X; Zhang F
    Aging (Albany NY); 2019 Jun; 11(11):3704-3715. PubMed ID: 31175266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates.
    Vita A; Minelli A; Barlati S; Deste G; Giacopuzzi E; Valsecchi P; Turrina C; Gennarelli M
    Front Pharmacol; 2019; 10():402. PubMed ID: 31040787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR143-3p-Mediated NRG-1-Dependent Mitochondrial Dysfunction Contributes to Olanzapine Resistance in Refractory Schizophrenia.
    Sun J; Zhang X; Cong Q; Chen D; Yi Z; Huang H; Wang C; Li M; Zeng R; Liu Y; Huai C; Chen L; Liu C; Zhang Y; Xu Y; Fan L; Wang G; Song C; Wei M; Du H; Zhu J; He L; Qin S
    Biol Psychiatry; 2022 Sep; 92(5):419-433. PubMed ID: 35662508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.